Evidence map›Paper›PMID 40496887›Full record

ReviewEClinicalMedicine2025

Clinicians must participate in the development of multimodal AI.

Christopher R S Banerji, Aroon Bhardwaj Shah, Ben Dabson, Tapabrata Chakraborti, Vicky Hellon, Chris Harbron, Ben D MacArthur

Abstract readReview
In one paragraph

Review in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christopher R S BanerjiThe Alan Turing Institute, London, UK.
Aroon Bhardwaj ShahWhittington Hospital, Whittington Health NHS Trust, London, UK.
Ben DabsonHammersmith Hospital, Imperial College London NHS Trust, London, UK.
Tapabrata ChakrabortiThe Alan Turing Institute, London, UK.
Vicky HellonThe Alan Turing Institute, London, UK.
Chris HarbronRoche Pharmaceuticals, Welwyn Garden City, UK.
Ben D MacArthurThe Alan Turing Institute, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multimodal artificial intelligence (AI) is a powerful new technological advance, capable of simultaneously learning from diverse data types, such as text, images, video, and audio. Because clinical decisions are usually based on information from multiple sources, multimodal AI has the potential to significantly improve clinical practice. However, unlike most developed multimodal AI workflows, clinical medicine is both a dynamic and interventional process in which the clinician continually learns about the patient's health and acts accordingly as data is collected. In this article we argue that multimodal clinical AI must be fully attuned to the particular challenges and constraints of the clinic, and clinician involvement is needed throughout development-not just at clinical deployment. We propose ways that clinician involvement can add value at each stage of the multimodal AI development pipeline, and argue for the establishment of actively managed multidisciplinary communities to work collaboratively towards the shared goal of improving the health of all.

Indexed as

Clinical AICommunity managementHealth policyHuman-in-the-loop AIMultimodal AI

Identifiers

PMID40496887
PMCPMC12151691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.